JNCCN-360

Advertisement

Advertisement

Brianna Hoffner, MSN, ANP-BC, AOCNP, on Managing Nivolumab Treatment Side Effects

Mark G. Kris, MD, on NSCLC: Juggling Sequence and Agent Choices in Lung Cancer

Matthew A. Gubens, MD, on Non–Small Cell Lung Cancer: Is There Still a Role for Chemotherapy?

Recent

Combination of Avelumab/Axitinib Approved by FDA for Advanced Renal Cell Carcinoma

Leronlimab Granted Fast Track Designation in Metastatic Triple-Negative Breast Cancer

Ado-Trastuzumab Emtansine Granted FDA Approval in HER2-Positive Early Breast Cancer

ELCC 2019: Patient-Reported Outcomes With Durvalumab in NSCLC

Published

Medical Literature

Combination Therapy May Be Key to Treating KRAS-Mutant NSCLC

Is Pertuzumab Plus Trastuzumab Effective in HER2-Amplified Colorectal Cancer?

First-Line Combination Therapy in Metastatic Kidney Cancer: Answers and More Questions

Viral Vector–Based Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

Ongoing

Immunotherapy for cSCC: How, Why, and When (login required)

Cases From the Community: Clinical Investigators Provide Their Perspectives on the Use of Immune Checkpoint Inhibitors in the Management of Actual Patients With Genitourinary Cancers

The Emerging Role of Immunotherapy in Head and Neck Cancers: An Integrated Approach (login required)

JADPRO Regional Lectures: Immunotherapy: Head & Neck Case Studies

Available

Clinical Trials

Immunotherapy Clinical Trials at Fred Hutch Cancer Research Center

Cancer Research Institute Immunotherapy Clinical Trials

ClinicalTrials.gov Immunotherapy

Center for Immunotherapy Clinical Research Trials

NCCN Resources

Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.